Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.
2.

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ.

Am J Pathol. 1997 Jan;150(1):297-303.

3.

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL.

Cancer Res. 1998 Feb 15;58(4):785-9.

4.

Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.

Xu S, Wei B, Zhang H, Qing M, Bu H.

Oncol Rep. 2008 Jun;19(6):1469-75.

PMID:
18497952
5.

Molecular alterations in columnar cell lesions of the breast.

Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S.

Mod Pathol. 2006 Mar;19(3):344-9.

6.

Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.

Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL.

J Pathol. 2006 Jul;209(3):307-16.

PMID:
16604511
7.

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.

Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL.

J Natl Cancer Inst. 2001 May 2;93(9):700-4.

PMID:
11333292
8.

The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.

Kang JH, Kim SJ, Noh DY, Choe KJ, Lee ES, Kang HS.

J Mol Med (Berl). 2001 Nov;79(11):648-55.

PMID:
11715068
9.

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

10.

Nuclear cytometric changes in breast carcinogenesis.

Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ.

J Pathol. 2001 Jan;193(1):33-9.

PMID:
11169513
11.

Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast.

Amari M, Moriya T, Ishida T, Harada Y, Ohnuki K, Takeda M, Sasano H, Horii A, Ohuchi N.

Jpn J Clin Oncol. 2003 Nov;33(11):556-62.

PMID:
14711979
12.

Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.

Lodato RF, Maguire HC Jr, Greene MI, Weiner DB, LiVolsi VA.

Mod Pathol. 1990 Jul;3(4):449-54.

PMID:
2170971
14.

Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.

Dunlap J, Le C, Shukla A, Patterson J, Presnell A, Heinrich MC, Corless CL, Troxell ML.

Breast Cancer Res Treat. 2010 Apr;120(2):409-18. doi: 10.1007/s10549-009-0406-1. Epub 2009 May 6.

PMID:
19418217
15.

Timing of critical genetic changes in human breast disease.

Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2005 Dec;12(12):1054-60. Epub 2005 Oct 10.

PMID:
16228814
16.

[Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].

Tang F, Gu DH, Wang H, Zhu TF, Zhu HG, Xu ZD, Hu XQ.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):192-5. Chinese.

PMID:
16875603
17.

Breast carcinogenesis. Transition from hyperplasia to invasive lesions.

Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, Uyar M.

Saudi Med J. 2005 Dec;26(12):1889-96.

PMID:
16380768
18.

Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.

Lisboa BW, Vogtländer S, Gilster T, Riethdorf L, Milde-Langosch K, Löning T.

Virchows Arch. 1997 Dec;431(6):375-81.

PMID:
9428925
19.

Cellular kinetics and expression of bcl-2 and p53 in ductal carcinoma of the breast.

Megha T, Ferrari F, Arcuri F, Lalinga AV, Lazzi S, Cardone C, Cevenini G, Leoncini L, Tosi P.

Oncol Rep. 2000 May-Jun;7(3):473-8.

PMID:
10767354
20.

20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast.

Werner M, Mattis A, Aubele M, Cummings M, Zitzelsberger H, Hutzler P, Höfler H.

Virchows Arch. 1999 Nov;435(5):469-72.

PMID:
10592049

Supplemental Content

Support Center